Clinical experience on Tocilizumab in RA

Speciality: Rheumatology


Speaker:

Dr. Sumeet Agrawal (Moderator) | Artemis Hospital

Dr. Rajeev Ranjan (Panelist) | CK Birla Hospital

Dr. Anu Daber (Panelist) | Paras Hospital

Dr. Sakshi Mittal (Panelist) | Venkateshwar Hospital

Dr. Sauvik das Gupta (Panelist) | Yashodha Hospital

Description:

A warm welcome to all the medical professionals in this interesting session on Clinical experience on Tocilizumab in RA
Tocilizumab, an IL-6 receptor antagonist, has demonstrated significant clinical benefits in managing rheumatoid arthritis (RA), particularly in patients with moderate to severe disease who do not respond well to traditional DMARDs or TNF inhibitors. Clinical experience with tocilizumab has shown that it effectively reduces inflammation, alleviates joint pain, and improves physical function by targeting the IL-6 pathway, which is heavily involved in RA’s inflammatory processes.
Patients treated with tocilizumab often experience reduced disease activity, fewer flare-ups, and slowed progression of joint damage. It can be used as monotherapy or in combination with other DMARDs, offering flexibility in treatment plans. However, its use requires careful monitoring, as tocilizumab can increase the risk of infections, alter liver enzyme levels, and affect lipid profiles. Overall, it has become an integral option in the treatment of RA, providing relief for patients who struggle with other therapies.
Therefore, get an overall knowledge of clinical experience on tocilizumab in RA
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.

2.

A small rise in cancer was observed following the 1986 Chernobyl accident.

3.

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

4.

The hidden costs of cancer for young survivors are derailing their financial futures

5.

Report reveals lung cancer is the leading cause of cancer deaths in Florida


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot